{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T20:44:35Z","timestamp":1788295475914,"version":"build-2803163510"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"51","license":[{"start":{"date-parts":[[2020,12,18]],"date-time":"2020-12-18T00:00:00Z","timestamp":1608249600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Shaoguan medical scientific research project","award":["Y17015"],"award-info":[{"award-number":["Y17015"]}]},{"name":"Shaoguan technology bureau project","award":["2017CX\/K011"],"award-info":[{"award-number":["2017CX\/K011"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>To Investigate the recent effects of small dose of folic acid on lipoprotein-associated phospholipase A2 (LP-PLA2) and systolic blood pressure variability in coronary heart disease (CHD) patients with hyperhomocysteinemia.<\/jats:p>\n            <jats:p>In this prospective cohort study, a total of 167 CHD patients with hyperhomocysteinemia were consecutively enrolled, and they were divided into Group A (without folic acid intervention, n = 99), Group B (with 0.4\u200amg of folic acid intervention, n\u200a=\u200a34), Group C (0.8\u200amg of folic acid intervention, n\u200a=\u200a34). General information, fasting blood glucose, and blood lipid, folic acid, homocysteine, Lp-PLA2, and blood pressure variability were compared among 3 groups. The above indicators were reviewed after 3 months of treatment.<\/jats:p>\n            <jats:p>There were no statistically significant differences of age, gender, blood pressure, incidence of type 2 diabetes mellitus, fasting blood glucose, folic acid, homocysteine, Lp-PLA2, total cholesterol, 3 acyl glycerin, apolipoprotein B, lipoprotein (a), high density lipoprotein cholesterol, and low density lipoprotein cholesterol were found among 3 groups (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&gt;\u200a.05); however, after being treated for 3 months, there was statistically significant difference in folic acid among 3 groups (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.05), there was statistically significant difference in apolipoprotein A between Group A and Group B (<jats:italic toggle=\"yes\">t<\/jats:italic>\u200a=\u200a0.505, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.039), and also between Group A and Group C (<jats:italic toggle=\"yes\">t<\/jats:italic>\u200a=\u200a0.052, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.017). There were statistically significant differences in Lp-PLA2 (<jats:italic toggle=\"yes\">t<\/jats:italic>\u200a=\u200a24.320, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.016) and systolic blood pressure variability (<jats:italic toggle=\"yes\">t<\/jats:italic>\u200a=\u200a0.154, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.018) between Group A and Group C.<\/jats:p>\n            <jats:p>For CHD patients with hyperhomocysteinemia, the higher dose (0.8\u200amg) of folic acid supplement was beneficial for increasing the apolipoprotein A, reducing the Lp-PLA2, and improving the systolic blood pressure variation, which might help to improve the prognosis in these patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000023573","type":"journal-article","created":{"date-parts":[[2020,12,17]],"date-time":"2020-12-17T21:37:11Z","timestamp":1608241031000},"page":"e23573","source":"Crossref","is-referenced-by-count":3,"title":["The recent effects of small dose of folic acid on lipoprotein-associated phospholipase A2 and systolic blood pressure variability in coronary heart disease patients with hyperhomocysteinemia"],"prefix":"10.1097","volume":"99","author":[{"given":"Xiangyang","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Cardiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangqiu","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Cardiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenmao","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Cardiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aihua","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jungang","family":"Pang","sequence":"additional","affiliation":[{"name":"Department of Cardiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjun","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Physical Diagnostics, Yue Bei People's Hospital Affiliated to Shantou University, Shaoguan, Guangdong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,12,18]]},"reference":[{"key":"R1-20240318","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1161\/ATVBAHA.108.179713","article-title":"The discovery of cellular immunity in the atherosclerotic plaque","volume":"29","author":"Hansson","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R2-20240318","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.3390\/ijms18102034","article-title":"New insights into the role of inflammation in the pathogenesis of atherosclerosis","volume":"18","author":"Wu","year":"2017","journal-title":"Int J Mol Sci"},{"key":"R3-20240318","first-page":"1","article-title":"Expression analysis of inflammatory response-associated genes in coronary artery disease","volume":"126","author":"Ebadi","year":"2020","journal-title":"Arch Physiol Biochem"},{"key":"R4-20240318","doi-asserted-by":"crossref","first-page":"E1109","DOI":"10.3390\/jcm8081109","article-title":"Inflammation as a therapeutic target in atherosclerosis","volume":"8","author":"Nguyen","year":"2019","journal-title":"J Clin Med"},{"key":"R5-20240318","doi-asserted-by":"crossref","first-page":"839","DOI":"10.15537\/smj.2015.7.11453","article-title":"Hyperhomocysteinemia as a metabolic disorder parameter is independently associated with the severity of coronary heart disease","volume":"36","author":"Liu","year":"2015","journal-title":"Saudi Med J"},{"key":"R6-20240318","first-page":"88","article-title":"Diagnostic value of Lp-PLA2 on Reverse-dipper blood pressure and severe stenosis of coronary artery in patients with coronary heart disease (Chinese)","volume":"27","author":"Liu","year":"2019","journal-title":"Pratical J Cardiac Cerebral Pneumal Vasvular Dis"},{"key":"R7-20240318","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.atherosclerosis.2015.06.033","article-title":"Lipoprotein associated phospholipase A2 activity, apolipoprotein C3 loss-of-function variants and cardiovascular disease: the atherosclerosis risk in communities study","volume":"241","author":"Pokharel","year":"2015","journal-title":"Atherosclerosis"},{"key":"R8-20240318","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/5584_2014_6","article-title":"C-reactive protein and lipoprotein-associated phospholipase A2 in smokers and nonsmokers of the Ludwigshafen Risk and Cardiovascular Health study","volume":"832","author":"Kleber","year":"2015","journal-title":"Adv Exp Med Biol"},{"key":"R9-20240318","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/hr.2017.4","article-title":"Analysis of beat-to-beat blood pressure variability response to the cold pressor test in the offspring of hypertensive and normotensive parents","volume":"40","author":"Wu","year":"2017","journal-title":"Hypertens Res"},{"key":"R10-20240318","doi-asserted-by":"crossref","first-page":"i4098","DOI":"10.1136\/bmj.i4098","article-title":"Blood pressure variability and cardiovascular disease: systematic review and meta-analysis","volume":"354","author":"Stevens","year":"2016","journal-title":"BMJ"},{"key":"R11-20240318","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s11906-013-0341-8","article-title":"Ambulatory blood pressure monitoring in the prediction and prevention of coronary heart disease","volume":"15","author":"Kang","year":"2013","journal-title":"Curr Hypertens Rep"},{"key":"R12-20240318","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.jacc.2016.06.054","article-title":"Association of systolic blood pressure variability with mortality, coronary heart disease, stroke, and renal disease","volume":"68","author":"Gosmanova","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"R13-20240318","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1001\/jamainternmed.2016.4687","article-title":"Efficacy of folic acid therapy on the progression of chronic kidney disease: the renal substudy of the china stroke primary prevention trial","volume":"176","author":"Xu","year":"2016","journal-title":"JAMA Intern Med"},{"key":"R14-20240318","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1001\/jama.2015.2274","article-title":"Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: the CSPPT randomized clinical trial","volume":"313","author":"Huo","year":"2015","journal-title":"JAMA"},{"key":"R15-20240318","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1161\/STROKEAHA.116.015324","article-title":"Homocysteine and stroke risk: modifying effect of methylenetetrahydrofolate reductase C677T polymorphism and folic acid intervention","volume":"48","author":"Zhao","year":"2017","journal-title":"Stroke"},{"key":"R16-20240318","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.3389\/fphar.2018.01159","article-title":"Association between folic acid supplementation and retinal atherosclerosis in Chinese adults with hypertension complicated by diabetes mellitus","volume":"9","author":"Meng","year":"2018","journal-title":"Front Pharmacol"},{"key":"R17-20240318","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/j.jacc.2007.11.079","article-title":"The effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity and cardiovascular biomarkers in patients with stable coronary heart disease or coronary heart disease risk equivalent: the results of a multicenter, randomized, double-blind, placebo-controlled study","volume":"51","author":"Mohler","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R18-20240318","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3349\/ymj.2016.57.2.321","article-title":"Darapladib, a lipoprotein-associated phospholipase A2 inhibitor, reduces rho kinase activity in atherosclerosis","volume":"57","author":"Zhang","year":"2016","journal-title":"Yonsei Med J"},{"key":"R19-20240318","first-page":"CD006612","article-title":"Homocysteine-lowering interventions for preventing cardiovascular events","volume":"8","author":"Mart\u00ed-Carvajal","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"R20-20240318","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.redox.2018.08.005","article-title":"Folic acid modulates VPO1 DNA methylation levels and alleviates oxidative stress-induced apoptosis in vivo and in vitro","volume":"19","author":"Cui","year":"2018","journal-title":"Redox Biol"},{"key":"R21-20240318","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1089\/gtmb.2017.0124","article-title":"MTRR A66G, RFC1 G80A, and MTHFR C677T and A1298C polymorphisms and disease activity in Mexicans with rheumatoid arthritis treated with methotrexate","volume":"21","author":"Gonzalez-Mercado","year":"2017","journal-title":"Genet Test Mol Biomarkers"},{"key":"R22-20240318","doi-asserted-by":"crossref","first-page":"e57917","DOI":"10.1371\/journal.pone.0057917","article-title":"Geographical distribution of MTHFR C677T, A1298C and MTRR A66G gene polymorphisms in China: findings from 15357 adults of Han nationality","volume":"8","author":"Yang","year":"2013","journal-title":"PLoS One"},{"key":"R23-20240318","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11745-012-3724-8","article-title":"High serum apolipoprotein E determines hypertriglyceridemic dyslipidemias, coronary disease and apoA-I dysfunctionality","volume":"48","author":"Onat","year":"2013","journal-title":"Lipids"},{"key":"R24-20240318","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.atherosclerosis.2009.01.023","article-title":"Congestive heart failure is associated with lipoprotein components in statin-treated patients with coronary heart disease Insights from the Incremental Decrease in End points Through Aggressive Lipid Lowering Trial (IDEAL)","volume":"205","author":"Holme","year":"2009","journal-title":"Atherosclerosis"},{"key":"R25-20240318","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.jacc.2016.06.054","article-title":"Association of systolic blood pressure variability with mortality, coronary heart disease, stroke, and renal disease","volume":"68","author":"Elvira","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"R26-20240318","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/MBP.0000000000000377","article-title":"Left ventricular hypertrophy in middle-aged endurance athletes: is it blood pressure related?","volume":"24","author":"Ma\u0142ek","year":"2019","journal-title":"Blood Press Monit"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000023573","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T11:11:20Z","timestamp":1710760280000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000023573"}},"subtitle":["A single-center prospective cohort study"],"short-title":[],"issued":{"date-parts":[[2020,12,18]]},"references-count":26,"journal-issue":{"issue":"51","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000023573","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,18]]}}}